P-glycoprotein in the placenta: Expression, localization, regulation and function
- 1 October 2006
- journal article
- review article
- Published by Elsevier BV in Reproductive Toxicology
- Vol. 22 (3), 400-410
- https://doi.org/10.1016/j.reprotox.2006.01.007
Abstract
No abstract availableThis publication has 108 references indexed in Scilit:
- Multidrug Resistance Phosphoglycoprotein (ABCB1) in the Mouse Placenta: Fetal Protection1Biology of Reproduction, 2005
- National Institute on Drug Abuse Conference report on placental proteins, drug transport, and fetal developmentAmerican Journal of Obstetrics and Gynecology, 2004
- Pharmacotherapy for pregnant women with addictionsAmerican Journal of Obstetrics and Gynecology, 2004
- DO MEN AND WOMEN DIFFER IN PROXIMAL SMALL INTESTINAL CYP3A OR P-GLYCOPROTEIN EXPRESSION?Drug Metabolism and Disposition, 2004
- Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defenseToxicology and Applied Pharmacology, 2004
- Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforinJournal of Pharmacy and Pharmacology, 2004
- Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitorsAIDS, 2000
- BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTERAnnual Review of Pharmacology and Toxicology, 1999
- Changes in the use profile 1987-1997 of Mectizan:Pathogens and Global Health, 1998
- MDR1 gene expression in solid tumoursEuropean Journal of Cancer, 1996